219 related articles for article (PubMed ID: 32454908)
21. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.
Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B
Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma.
Tsujitani S; Saito H; Oka S; Sakamoto T; Kanaji S; Tatebe S; Ikeguchi M
Dig Dis Sci; 2007 Feb; 52(2):549-54. PubMed ID: 17211709
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
24. Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma.
Zhu Y; Zhang X
PeerJ; 2019; 7():e7918. PubMed ID: 31667016
[TBL] [Abstract][Full Text] [Related]
25. PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
Tao Y; Liang B
Pathol Res Pract; 2020 Jun; 216(6):152943. PubMed ID: 32279917
[TBL] [Abstract][Full Text] [Related]
26. Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer.
Reddy SM; Reuben A; Barua S; Jiang H; Zhang S; Wang L; Gopalakrishnan V; Hudgens CW; Tetzlaff MT; Reuben JM; Tsujikawa T; Coussens LM; Wani K; He Y; Villareal L; Wood A; Rao A; Woodward WA; Ueno NT; Krishnamurthy S; Wargo JA; Mittendorf EA
Cancer Immunol Res; 2019 Jun; 7(6):1025-1035. PubMed ID: 31043414
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.
Yakirevich E; Lu S; Allen D; Mangray S; Fanion JR; Lombardo KA; Safran H; Resnick MB
Hum Pathol; 2017 Aug; 66():126-135. PubMed ID: 28666927
[TBL] [Abstract][Full Text] [Related]
28. Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.
Baba Y; Nomoto D; Okadome K; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Baba H
Cancer Sci; 2020 Sep; 111(9):3132-3141. PubMed ID: 32579769
[TBL] [Abstract][Full Text] [Related]
29. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma.
Ikeguchi M; Ikeda M; Tatebe S; Maeta M; Kaibara N
Oncol Rep; 1998; 5(5):1185-9. PubMed ID: 9683832
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
34. Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients.
Daiko H; Marafioti T; Fujiwara T; Shirakawa Y; Nakatsura T; Kato K; Puccio I; Hikichi T; Yoshimura S; Nakagawa T; Furukawa M; Stoeber K; Nagira M; Ide N; Kojima T
Cancer Immunol Immunother; 2020 Nov; 69(11):2247-2257. PubMed ID: 32500232
[TBL] [Abstract][Full Text] [Related]
35. Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer.
Li F; Guo H; Wang Y; Liu B; Zhou H
Int Immunopharmacol; 2020 Aug; 85():106641. PubMed ID: 32470882
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.
Zhao T; Li C; Wu Y; Li B; Zhang B
PLoS One; 2017; 12(4):e0176822. PubMed ID: 28453554
[TBL] [Abstract][Full Text] [Related]
37. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
[TBL] [Abstract][Full Text] [Related]
38. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.
Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M
Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088
[TBL] [Abstract][Full Text] [Related]
39. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
40. Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.
Nishimura J; Tanaka H; Yamakoshi Y; Hiramatsu S; Tamura T; Toyokawa T; Muguruma K; Maeda K; Hirakawa K; Ohira M
Esophagus; 2019 Oct; 16(4):333-344. PubMed ID: 30968254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]